The Catheter Stabilization Devices Market Outlook And Analysis
by Product type (arterial securement devices, chest drainage tube securement
devices), Applications (cardiovascular procedures, radiology, respiratory
procedures) - Forecast till 2030
Market Research Future (MRFR) latest study finds
that the global catheter stabilization market is set to surge at 7.1% CAGR from
2022 to 2030. Catheter stabilization devices are standard class for suture-free
stabilization of peritoneal lavage and nephrostomy and biliary percutaneous
drainage catheters.
These devices play an important during procedures
that involve the use of catheters.
Cardiac, neurology, urological are among the major areas where catheter
stabilization finds application. The rising incidence of cardiac incidence is
one of the major factors driving the market growth. In 2015, cardiovascular
diseases accounted for more than 17 Mn deaths. Of these, over 6 Mn deaths were
due to stroke and more than 7 Mn were due to coronary heart diseases. The data
released by the American Heart Association cardiovascular diseases accounted
for nearly 801,000 deaths in 2017. The healthcare cost of cardiovascular
treatment is anticipated to reach USD 1044 Bn by the year 2020.
Segmental
Overview
MRFR’s study includes a detailed segmental analysis
of the global catheter stabilization market share based on
application, product type, end user and region.
By application, the market has been segmented into
respiratory procedures, general surgery, radiology, cardiovascular procedures,
urological procedures, gastric and oropharyngeal procedures and others. By
product type, the market has been segmented into arterial securement devices,
central venous catheter securement devices, peripheral securement devices,
chest drainage tube securement devices, abdominal drainage tubes securement
devices, epidural securement devices. The central venous catheter securement
devices segment covers jugular securement devices, PICC securement devices,
midlines securement devices, portal securement devices, subclavian securement
devices and femoral securement devices. The peripheral securement devices
segment covers nasogastric tubes securement devices, continuous nerve block
catheter securement devices, chest drainage tube securement devices, foley
catheter securement devices, endotracheal tube securement devices,
ventriculoperitoneal securement devices. Abdominal drainage tube securement
devices segment covers umbilical catheter securement devices, jejunal catheter
securement devices and percutaneous endoscopic gastrostomy securement devices. By end users, the market
has been segmented into diagnostic centers, home healthcare providers and
hospitals & clinics.
Global Catheter
stabilization market: Regional Segmentation
On the basis of region, the market has been
segmented into Asia Pacific, Europe, Americas and the Middles East & Africa
(MEA). The market catheter stabilization market share in Americas is expected
to remain highly attractive during the forecast period. Presence of advanced
healthcare infrastructure and faster adoption of innovative healthcare technologies
are some of factors supporting the market growth in Americas, especially North
America.
In terms of revenue, Europe holds the second spot.
Increased prevalence of chronic diseases and cardiovascular disorders in the
region is driving the demand for catheter-based procedures. Moreover, high
healthcare expenditure and presence of public healthcare policies continues to
favour the market in Europe.
Asia Pacific is also viewed as a crucial market for
catheter stabilization. In fact, the APAC catheter stabilization market share
is projected to witness a relatively faster growth during the forecast period.
Growing need for effective diagnostic services and increased focus of improving
healthcare infrastructure and an ever-growing patient pools are factors that
make APAC a market with significant potentials.
Competitive
Analysis
Some of top-notch companies operating in the global
catheter stabilization market share include B. Braun Melsungen Ag, C. R. Bard,
Inc. Convatec, Inc., Medtronic PLC, M.C. Johnson Company, Inc., 3M Company,
TIDI Products, LLC., Baxter International, Inc., Merit Medical Systems, Inc.,
Centurion Medical Products, and Smiths Group PLC.
Industry News
·
American healthcare technology company Abbott
Laboratories has reportedly received the green signal from FDA for its novel
sensor enabled TactiCath Contract Force Ablation Catheter. The catheter has
been there in the Europe market for couple of years now.
·
Penumbra, a healthcare company that develops
suction-based stroke clot removal devices has recently introduce two new
devices; Penumbra JET 7 and Penumbra JET D Reperfusion Catheters.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments